Vir Biotechnology (VIR)
(Real Time Quote from BATS)
$9.30 USD
+0.04 (0.43%)
Updated Nov 4, 2024 03:16 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/27/25 |
---|---|
Current Quarter | -0.86 |
EPS Last Quarter | -1.56 |
Last EPS Surprise | -62.50% |
ABR | 1.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.26 |
Next Year | -3.53 |
EPS (TTM) | -3.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.95M | 21.57M | 79.47M | 62.07M |
# of Estimates | 3 | 2 | 4 | 3 |
High Estimate | 39.80M | 40.10M | 120.60M | 106.20M |
Low Estimate | 2.17M | 3.04M | 59.50M | 12.15M |
Year ago Sales | 16.79M | 56.38M | 86.18M | 79.47M |
Year over Year Growth Est. | -10.96% | -61.74% | -7.78% | -21.90% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.86 | -0.85 | -3.26 | -3.53 |
# of Estimates | 4 | 2 | 6 | 6 |
Most Recent Consensus | -0.71 | -0.72 | -3.05 | -2.86 |
High Estimate | -0.71 | -0.72 | -3.05 | -2.86 |
Low Estimate | -1.03 | -0.98 | -3.40 | -4.00 |
Year ago EPS | -0.86 | -0.48 | -4.59 | -3.26 |
Year over Year Growth Est. | 0.00% | -77.08% | 28.98% | -8.38% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.86 | -0.85 | -3.26 | -3.53 |
7 Days Ago | -0.86 | -0.85 | -3.26 | -3.53 |
30 Days Ago | -0.86 | -0.85 | -3.26 | -3.53 |
60 Days Ago | -0.86 | -0.85 | -3.26 | -3.53 |
90 Days Ago | -0.86 | -0.80 | -3.31 | -3.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.86 | -0.85 | -3.26 | -3.53 |
Zacks Consensus Estimate | -0.86 | -0.85 | -3.26 | -3.53 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.56 | -1.02 | -0.48 | -0.86 | NA |
Estimate | -0.96 | -0.93 | -0.99 | -1.14 | NA |
Difference | -0.60 | -0.09 | 0.51 | 0.28 | 0.03 |
Surprise | -62.50% | -9.68% | 51.52% | 24.56% | 0.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more